State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activation.
The voltage-sensing domain of voltage-gated channels is comprised of four transmembrane helices (S1-S4), with conserved positively charged residues in S4 moving across the membrane in response to changes in transmembrane voltage. Although it has been shown that positive charges in S4 interact with negative countercharges in S2 and S3 to facilitate protein maturation, how these electrostatic interactions participate in channel gating remains unclear. We studied a mutation in Kv7.1 (also known as KCNQ1 or KvLQT1) channels associated with long QT syndrome (E1K in S2) and found that reversal of the charge at E1 eliminates macroscopic current without inhibiting protein trafficking to the membrane. Pairing E1R with individual charge reversal mutations of arginines in S4 (R1-R4) can restore current, demonstrating that R1-R4 interact with E1. After mutating E1 to cysteine, we probed E1C with charged methanethiosulfonate (MTS) reagents. MTS reagents could not modify E1C in the absence of KCNE1. With KCNE1, (2-sulfonatoethyl) MTS (MTSES)(-) could modify E1C, but [2-(trimethylammonium)ethyl] MTS (MTSET)(+) could not, confirming the presence of a positively charged environment around E1C that allows approach by MTSES(-) but repels MTSET(+). We could change the local electrostatic environment of E1C by making charge reversal and/or neutralization mutations of R1 and R4, such that MTSET(+) modified these constructs depending on activation states of the voltage sensor. Our results confirm the interaction between E1 and the fourth arginine in S4 (R4) predicted from open-state crystal structures of Kv channels and reveal an E1-R1 interaction in the resting state. Thus, E1 engages in electrostatic interactions with arginines in S4 sequentially during the gating movement of S4. These electrostatic interactions contribute energetically to voltage-dependent gating and are important in setting the limits for S4 movement.
Wu
Dick
D
Department of Biomedical Engineering and Cardiac Bioelectricity and Arrhythmia Center, Washington University, St. Louis, MO 63130, USA.
Delaloye
Kelli
K
Zaydman
Mark A
MA
Nekouzadeh
Ali
A
Rudy
Yoram
Y
Cui
Jianmin
J
D000595:Amino Acid Sequence; D000818:Animals; D001120:Arginine; D002462:Cell Membrane / Q000378:metabolism; D003545:Cysteine; D015640:Ion Channel Gating / Q000187:drug effects; D051657:KCNQ1 Potassium Channel / Q000737:chemistry / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D008133:Long QT Syndrome / Q000235:genetics / Q000378:metabolism*; D008564:Membrane Potentials; D008698:Mesylates / Q000494:pharmacology; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009154:Mutation; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013499:Surface Properties; D013997:Time Factors; D014981:Xenopus
D051657:KCNQ1 Potassium Channel; D008698:Mesylates; D013439:Sulfhydryl Reagents; C109153:(2-sulfonatoethyl)methanethiosulfonate; C109154:(2-(trimethylammonium)ethyl)methanethiosulfonate; D001120:Arginine; D003545:Cysteine